Abivax
ABVX
#1843
Rank
NZ$20.22 B
Marketcap
NZ$253.75
Share price
9.12%
Change (1 day)
1,891.18%
Change (1 year)

Market capitalization of Abivax (ABVX)

Market cap: NZ$20.22 Billion

As of July 2026 Abivax has a market cap of NZ$20.22 Billion. This makes Abivax the world's 1843th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Abivax from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.22 B4.3%
2025NZ$19.38 B2353.9%
2024NZ$0.79 B-26.92%
2023NZ$1.08 B367.22%
2022NZ$0.23 B-70.82%
2021NZ$0.79 B-5.49%
2020NZ$0.83 B83.64%
2019NZ$0.45 B121.85%
2018NZ$0.20 B43.86%
2017NZ$0.14 B54.29%
2016NZ$92.78 M-57.48%
2015NZ$0.21 B

End of Day market cap according to different sources

On Jul 1st, 2026 the market cap of Abivax was reported to be:

NZ$18.43 Billion
by Nasdaq info icon info icon
NZ$18.53 Billion
by CompaniesMarketCap info icon info icon